MOSAIQUES DIAGNOSTICS GMBH - Germany 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:900-1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2014
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2013
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:400-500
Total Number of Projects:69
Total Project Funding:300-400
Partner Constancy:51
Project Leadership Index:69
Diversity Index:41
2012
Criterium:Position:
Overall Score:500-600
Total Project Funding per Partner:500-600
Total Number of Projects:66
Total Project Funding:400-500
Networking Rank (Reputation):600-700
Networking Rank (Reputation):600-700
Partner Constancy:34
Project Leadership Index:71
Diversity Index:60
2011
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2010
Criterium:Position:
Overall Score:400-500
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:700-800
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:500-600
Diversity Index:900-1000
2009
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2008
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000
2007
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:> 1000
Total Number of Projects:> 1000
Total Project Funding:> 1000
Networking Rank (Reputation):> 1000
Partner Constancy:> 1000
Project Leadership Index:> 1000
Diversity Index:> 1000

Ranking timeline:

Project Participation Performance(2010-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 30
As coordinator: 2
As participant: 22
Sole participant: 6
Coordinator / Participant Ratio: 0.09*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 1.648.915 521.078 1
2020 162.806 9.332.071 1.116.645 1 2
2018 342.922 2.795.346 592.138 2 1
2017 275.711 2.629.316 275.711 2 1
2016 0 387.000 148.500 1
2015 0 7.804.961 498.433 3
2014 50.000 5.976.413 783.600 1 1
2013 0 35.995.491 3.003.606 5
2012 668.455 24.386.507 2.988.261 1 4
2011 0 5.990.880 788.875 1
2010 609.297 14.789.034 1.141.552 1 2

Networking:

Partners:

Institution:Projects [No]:
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE12
UNIVERSITY OF GLASGOW8
IDRYMA IATROVIOLOGIKON EREUNON AKADEMIAS ATHINON6
KATHOLIEKE UNIVERSITEIT LEUVEN6
UNIVERSITAETSKLINIKUM AACHEN6
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI5
MEDIZINISCHE HOCHSCHULE HANNOVER5
ACADEMISCH ZIEKENHUIS GRONINGEN4
BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS4
CHARITE UNIVERSITAETSMEDIZIN BERLIN4
EMERGENTEC BIODEVELOPMENT4
RD NEPHROLOGIE SAS4
THE UNIVERSITY OF MANCHESTER4
UNIVERSITY COLLEGE DUBLIN NATIONAL UNIVERSITY OF IRELAND DUBLIN4
FUNDACION PARA LA INVESTIGACION MEDICA APLICADA3
INSERM TRANSFERT3
MEDIZINISCHE UNIVERSITAET WIEN3
SERVICEXS BV3
UNIVERSITAET ZUERICH3
UNIVERSITAETSKLINIKUM HEIDELBERG3
UNIVERSITEIT MAASTRICHT3
UNIVERSITY OF NEWCASTLE UPON TYNE3
WEIZMANN INSTITUTE OF SCIENCE3
ACQUIFER2
ACS BIOMARKER BV2
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS2
AZIENDA OSPEDALIEROUNIVERSITARIA DI PARMA2
BIOCRATES LIFE SCIENCES2
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE2
CONSIGLIO NAZIONALE DELLE RICERCHE2
FOUNDATION FOR RESEARCH AND TECHNOLOGY HELLAS2
FUNDACIO INSTITUT D'INVESTIGACIO BIOMEDICA DE BELLVITGE2
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT2
INSTITUTO INVESTIGACION SANITARIA FUNDACION JIMENEZ DIAZ2
KAROLINSKA INSTITUTE2
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN2
MEDIZINISCHE UNIVERSITAET GRAZ2
MEDIZINISCHE UNIVERSITAT INNSBRUCK2
OULUN YLIOPISTO2
RANDOX CLINICS LIMITED2
SS CYRIL AND METHODIUS UNIVERSITY IN SKOPJE2
STENO DIABETES CENTER2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITE DE BORDEAUX2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
ACUREOMICS AB1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
ALMAC DIAGNOSTIC SERVICES LIMITED1
AMGEN1
ATLAS BIOLABS1
AVANTICELL SCIENCE1
AZIENDA SANITARIA DI FIRENZE1
BAKER IDI HEART AND DIABETES INSTITUTE HOLDINGS LIMITED1
BAYER1
BEATSON INSTITUTE FOR CANCER RESEARCH LBG1
BIOGAZELLE1
BIOLUTION1
BIOMEDCODE HELLAS1
BIOMEDICAL SCIENCES RESEARCH CENTER ALEXANDER FLEMING1
CANCER RESEARCH UK LBG1
CARDIFF METROPOLITAN UNIVERSITY1
CARDINAL SYSTEMS1
CARVER WILDE COMMUNICATIONS1
CELERA CORPORATION1
CENTRE HOSPITALIER UNIVERSITAIRE DE LIMOGES1
CENTRE HOSPITALIER UNIVERSITAIRE DE TOULOUSE1
COMMISSARIAT A L'ENERGIE ATOMIQUE1
COMPREHENSIVE BIOMARKER CENTER1
DIABETES AND VASCULAR RESEARCH FOUNDATION1
DIABETOLOGEN HESSEN EG1
DIAGENODE1
DIAGNOSWISS1
DSM MATERIALS SCIENCE CENTER BV1
EAGLE GENOMICS LIMITED1
EBERHARD KARLS UNIVERSITAET TUEBINGEN1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
EMORY UNIVERSITY NON PROFIT CORP1
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM1
EUROPEAN ASSOCIATION OF UROLOGY1
EUROPEAN SOCIETY FOR ARTIFICIAL ORGANS1
EVERCYTE1
FONDATION TRANSPLANTATION1
FONDAZIONE ISTITUTO ITALIANO DI TECNOLOGIA1
FRESENIUS MEDICAL CARE DEUTSCHLAND1
FRIEDRICH SCHILLER UNIVERSITAET JENA1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION PARA LA INVESTIGACION DEL HOSPITAL CLINICO DE LA COMUNITAT VALENCIANA FUNDACION INCLIVA1
GABO:MI GESELLSCHAFT FUR ABLAUFORGANISATION:MILLIARIUM MBH & CO KG GAB O1
GENIKO NOSOKOMEIO ATHINAS IPPOKRATEIO1
GENOMATIX SOFTWARE1
GENOMESCAN BV1
GWTTUD1
HACETTEPE UNIVERSITESI1
HANNOVER CLINICAL TRIAL CENTER1
HELSINGIN YLIOPISTO1
HOSPICES CANTONAUX CHUV1
HYBRIDSTAT PREDICTIVE ANALYTICS OE1
ICON PLC1
IFOM FONDAZIONE ISTITUTO FIRC DI ONCOLOGIA MOLECOLARE1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1

Constancy:

Total number of partners: 286
Partner loyalty:
Frequent Partner: (> 2 projects): 103
Rare Partner: 183
Frequent / Rare Partner Ratio: 0.56

Project overview:

Start dateProjectacronymrolefundingpartners
2022-09-01Discovering Collagen I degradation process in chronic diseases with fibrotic component DisCo-Iparticipant1.648.9159
2020-06-01Novel therapeutic approaches, based on drug repurposing, for high risk non muscle invasive bladder cancer driven by patients’ proteomic signatures ReDrugBCcoordinator162.8061
2020-02-01System omics to unravel the gut-kidney axis in Chronic Kidney Disease. STRATEGY-CKDparticipant3.363.59112
2020-01-01Drug combinations for rewriting trajectories of renal pathologies in type II diabetes (DC-ren) DC-renparticipant5.968.4808
2018-08-01Proteomics for Chronic Kidney Disease Therapy PROCEEDcoordinator171.4611
2018-04-01Multi-omics molecular treatment targets for Prostate Cancer PCaProTreatcoordinator171.4611
2018-01-01Combatting the CardioRenal Syndrome: towards an integrative Analysis to reduce cardiovascular burden in chronic kidney disease CaReSyAnparticipant2.795.34615
2017-09-29Integration of high resolution -OMICS datasets towards personalized therapy in bladder cancer TheranOMICScoordinator116.2501
2017-04-01Molecular profiling of Bladder Cancer to support personalized medicine BioMedBCcoordinator159.4611
2017-01-01Translational Research Network in Prostate Cancer TransPotparticipant2.629.31618
2016-01-01PRoteome-based assessment of vascular disease for the Establishment of a Translational REsearch plATform PRETREATparticipant387.0005
2015-07-01Fellowship Programme supporting Career Development and Interdisciplinary Training in Omics driven Personalised Medicine TOPMed10participant885.0007
2015-06-01Development and disease of the renal tract RENALTRACTparticipant3.137.3778
2015-01-01Chromatin Dynamics in Development and Disease Chromatin3Dparticipant3.782.58312
2014-11-01Biomarker Guided Prostate Cancer Management BioGuidePCacoordinator50.0001
2014-02-01Systems Biology to Identify Molecular Targets for Vascular Disease Treatment SYSVASCparticipant5.976.41317
2013-09-01Clinical and system –omics for the identification of the MOlecular DEterminants of established Chronic Kidney Disease IMODE-CKDparticipant2.794.78910
2013-09-01Translation of novel Biomarkers for Bladder Cancer for clinical outcome prediction TRANSBIOBCparticipant3.260.3594
2013-03-01Biomarkers of renal graft injuries in kidney allograft recipients BIOMARGINparticipant6.000.00013
2013-02-01Heart OMics in AGEing HOMAGEparticipant12.000.00018
2013-01-01"Utility of omic-based biomarkers in characterizing older individuals at risk for frailty, its progression to disability and general consequences to health and well-being - The FRAILOMIC Initiative" FRAILOMICparticipant11.940.34323
2012-12-01Translational research (training) in Polycystic Kidney Disease TRANCYSTparticipant2.763.7337
2012-10-01The role of Chronic DNA damage in Ageing and Age-related pathology CodeAgeparticipant3.647.7079
2012-10-01Molecular Medicine for Bladder Cancer BCMolMedcoordinator668.4552
2012-10-01European Consortium for High-Throughput Research in Rare Kidney Diseases EURENOMICSparticipant11.994.56728
2012-01-01Proteomic prediction and Renin angiotensin aldosterone system Inhibition prevention Of early diabetic nephRopathy In TYpe 2 diabetic patients with normoalbuminuria PRIORITYparticipant5.980.50020
2011-12-01Markers for Sub-Clinical Cardiovascular Risk Assessemnt EU-MASCARAparticipant5.990.88016
2010-11-01Host and viral factors in acute hepatitis C HepaCuteparticipant2.999.50017
2010-05-15IMPROVEMENT OF TOOLS AND PORTABILITY OF MASS SPECTROMETRY-BASED CLINICAL PROTEOMICS AS APPLIED TO CHRONIC KIDNEY DISEASE PROTOCLINcoordinator609.2973
2010-01-01Systems biology towards novel chronic kidney disease diagnosis and treatment SysKIDparticipant11.789.53429

Alias institution names:

  • MOSAIQUES DIAGNOSTICS